1. Home
  2. NVST vs KRYS Comparison

NVST vs KRYS Comparison

Compare NVST & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVST
  • KRYS
  • Stock Information
  • Founded
  • NVST 2018
  • KRYS 2015
  • Country
  • NVST United States
  • KRYS United States
  • Employees
  • NVST N/A
  • KRYS N/A
  • Industry
  • NVST Medical/Dental Instruments
  • KRYS Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • NVST Health Care
  • KRYS Health Care
  • Exchange
  • NVST Nasdaq
  • KRYS Nasdaq
  • Market Cap
  • NVST 3.3B
  • KRYS 3.6B
  • IPO Year
  • NVST 2019
  • KRYS 2017
  • Fundamental
  • Price
  • NVST $18.28
  • KRYS $125.96
  • Analyst Decision
  • NVST Buy
  • KRYS Strong Buy
  • Analyst Count
  • NVST 12
  • KRYS 8
  • Target Price
  • NVST $20.55
  • KRYS $211.13
  • AVG Volume (30 Days)
  • NVST 2.7M
  • KRYS 436.2K
  • Earning Date
  • NVST 05-01-2025
  • KRYS 05-06-2025
  • Dividend Yield
  • NVST N/A
  • KRYS N/A
  • EPS Growth
  • NVST N/A
  • KRYS 109.01
  • EPS
  • NVST N/A
  • KRYS 4.16
  • Revenue
  • NVST $2,503,900,000.00
  • KRYS $333,448,000.00
  • Revenue This Year
  • NVST $3.36
  • KRYS $48.66
  • Revenue Next Year
  • NVST $3.24
  • KRYS $49.81
  • P/E Ratio
  • NVST N/A
  • KRYS $30.31
  • Revenue Growth
  • NVST N/A
  • KRYS 247.53
  • 52 Week Low
  • NVST $14.22
  • KRYS $122.80
  • 52 Week High
  • NVST $23.00
  • KRYS $219.34
  • Technical
  • Relative Strength Index (RSI)
  • NVST 57.98
  • KRYS 31.65
  • Support Level
  • NVST $16.41
  • KRYS $123.03
  • Resistance Level
  • NVST $18.72
  • KRYS $127.59
  • Average True Range (ATR)
  • NVST 0.61
  • KRYS 4.59
  • MACD
  • NVST 0.06
  • KRYS 0.39
  • Stochastic Oscillator
  • NVST 64.53
  • KRYS 18.15

About NVST Envista Holdings Corporation

Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments comprising Specialty Products and Technologies and Equipment and Consumables. The Company's Specialty Products & Technologies segment develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. The Company's Equipment & Consumables segment manufactures dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems.

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

Share on Social Networks: